Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the complete record of transactions filed by Guyer William. Insider active across 2 companies, notably CORCEPT THERAPEUTICS INC. Cumulatively, 49 filings have been published. Split: 0 buy · 8 sells. Total volume traded: €5.8m. History available since 1 September 2022. The latest transaction was filed on 10 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Guyer William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Guyer William is Chief Development Officer at CORCEPT THERAPEUTICS INC and Corcept Therapeutics INC, both on XNAS. He has 44 filings in total, and across the recent filings tracked, the period runs from 2022-09-06 to 2026-07-08, with €0 of buys and €3,860,200 of sells, and the most common transaction nature is option exercise.